Form 4 · LLY
Eli Lilly director Gabrielle Sulzberger reports an award of about 4 shares
Gabrielle Sulzberger, an Eli Lilly director, filed a Form 4 on Oct 20, 2026 at 4:36 PM ET reporting transactions on Oct 19, 2026.
The filing reports about 4 shares in a grant or award (code A).
After these transactions, the filing lists about 3,016 shares held directly.
Effect on holdings
Taken together, the rows reported here raised Gabrielle Sulzberger's directly held shares by 0.1%, from about 3,012 to about 3,016.
Reporting person
- Gabrielle Sulzberger, director (as filed: Sulzberger Gabrielle)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-10-19 | A | Common Stock | 4 | $1,240.34 | Acquired | 3,016 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Oct 20, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Eli Lilly company file → · More Eli Lilly filings
Disclosures
- Editor holdings in LLY
- The editor holds no position in Eli Lilly (LLY). As of Oct 25, 2026.
- Last updated
- Oct 25, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold LLY.